Hanmi Science Co., Ltd. Stock Price

KOSE:A008930 Community·₩2.6t Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

A008930 Share Price Performance

₩0

-32250.00 (-100.00%)

₩0

-32250.00 (-100.00%)

₩0

Mon, 1 Dec 25

Share Pricen/a

A008930 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

0 Risks

1 Reward

View Full Analysis

Hanmi Science Co., Ltd. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 1.11k
: 22.26%
: 5.60%
: 22.9%

View Full Analysis

About A008930

Founded: 1973
Employees: 444
CEO: Jong-Hoon Lim
WebsiteView website: www.hanmiscience.co.kr

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult’s bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.